The Nanjing Institute for Biological and Pharmaceutical Innovation and Transformation was officially established.

According to the Qichacha APP, recently, Nanjing Institute of Biological Medicine Innovation and Transformation Research Co., Ltd. was established, with Wu Ruibin as the legal representative, registered capital of 2 million RMB, and business scope including technology promotion and application services, entrepreneurship space services, technology intermediary services, etc. Qichacha's equity penetration shows that the company is jointly held by Nanjing China Pharmaceutical University Education Development Foundation, etc.